Literature DB >> 2413178

Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features.

R W Walker, E J Thompson, W I McDonald.   

Abstract

Cerebrospinal fluid (CSF) from 120 patients with multiple sclerosis was analyzed by polyacrylamide gel electrophoresis, as well as routine laboratory microscopy and assays of total protein and immunoglobulin G (IgG). Negative correlations were found between leucocyte counts and patient age, duration of disease and time from last clinical relapse. There was a positive correlation between the leucocyte count and amount of gammaglobulin. A correlation between gammaglobulin content and degree of disability was found. With increasing duration, the gammaglobulin concentration rose only if there was increasing disability. In terms of correlations with clinical features, differences existed depending on whether IgG was assayed immunologically or by electrophoresis and densitometry. Evidence of increased blood: CSF barrier permeability (transudation of high molecular weight proteins) was found in patients with progressive disease. The presence of oligoclonal bands was the CSF abnormality most frequently encountered.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413178     DOI: 10.1007/bf00313789

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  78 in total

1.  FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1965-07       Impact factor: 9.910

2.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

3.  The cerebrospinal fluid in multiple sclerosis.

Authors:  D A FREEDMAN; H H MERRITT
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1950

4.  Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis.

Authors:  H Link
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

5.  Protein size and cerebrospinal fluid composition.

Authors:  K Felgenhauer
Journal:  Klin Wochenschr       Date:  1974-12-15

6.  Multifocal areas of synthesis of immunoglobulin-G in multiple sclerosis brain tissue and the sink action of the cerebrospinal fluid.

Authors:  W W Tourtellotte; H H Itabashi; J A Parker
Journal:  Trans Am Neurol Assoc       Date:  1967

7.  The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis.

Authors:  D Moulin; D W Paty; G C Ebers
Journal:  Brain       Date:  1983-12       Impact factor: 13.501

8.  Relationships between abnormal IgG index, oligoclonal bands, acute phase reactants and some clinical data in multiple sclerosis.

Authors:  O Christensen; J Clausen; T Fog
Journal:  J Neurol       Date:  1978-08-25       Impact factor: 4.849

9.  Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis.

Authors:  E J Thompson; P Kaufmann; R C Shortman; P Rudge; W I McDonald
Journal:  Br Med J       Date:  1979-01-06

10.  Follow-up of patients with suspected multiple sclerosis: a clinical and electrophysiological study.

Authors:  J Bøttcher; W Trojaborg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

View more
  5 in total

1.  Fluids of the brain and the pathogenesis of MS.

Authors:  E J Thompson; A Zeman
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

2.  Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  H W Kölmel; C Sudau
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

Review 3.  Cerebrospinal fluid.

Authors:  E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

4.  Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis.

Authors:  B N McLean; A Z Zeman; D Barnes; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

5.  Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis.

Authors:  Katja Vohl; Alexander Duscha; Barbara Gisevius; Johannes Kaisler; Ralf Gold; Aiden Haghikia
Journal:  Front Neurol       Date:  2019-02-22       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.